Skip to content
Primary Menu
Clinical
Medications for Opioid Use Disorder (MOUD)
Buprenorphine Low-Dose Induction using a Cross-Tapering Strategy
Methadone Resources for Providers
Pain or Opioid Withdrawal in Hospitalized Patients
Xylazine Withdrawal and Overdose
Xylazine Wounds
Alcohol Use
Substance Use Navigator Team
Success Stories
Education
Students
President’s Engagement Prize
Trainings
Addiction Medicine Fellowship
All About the X Waiver
Working as a Peer in Recovery
Events
Community & Harm Reduction Resources
Community
Community Advisory Board (CAB)
Sustaining Peers in the ED (SPED)
Harm Reduction
All About Fentanyl
All About Xylazine
How to Use Narcan
How to Mitigate Stigma
One-Page Resources
Volunteer & Events Calendar
Join Us at Outreach Events!
Volunteer Harm Reduction Interest Group
Research, Projects & Policy
Our Work
CareConnect Warmline
Addiction Medicine Consult Service
Police-Assisted Diversion (PAD)
Project HOME
PROUD Clinic
NACCHO
Clinical Trials
Research
News
Policy
Publications
About Us
Leadership
Advisory Board
Faculty
CAMP Team
Team Spotlight
Newsletters
Donate
Get Help
Publications
Association of Urine Fentanyl Concentration With Severity of Opioid Withdrawal Among Patients Presenting to the Emergency Department
Journal of Addiction Medicine | August 1, 2023
Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder
Academic Emergency Medicine | July 28, 2023
Impact of Universal Screening and Automated Clinical Decision Support for the Treatment of Opioid Use Disorder in Emergency Departments: A Difference-in-Differences Analysis
Annals of Emergency Medicine | June 14, 2023
National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use Disorder
Annals of Emergency Medicine | May 12, 2023
Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature
Frontiers in Public Health | April 20, 2023
An analysis of cannabinoid hyperemesis syndrome Reddit posts and themes
Clinical Toxicology | April 4, 2023
Self-reported Xylazine Experiences: A Mixed Methods Study of Reddit Subscribers
medRxiv | March 14, 2023
Incidence of Precipitated Withdrawal During a Multisite Emergency Department-Initiated Buprenorphine Clinical Trial in the Era of Fentanyl
JAMA Network Open | March 1, 2023
This Philly clinic gets patients with opioid addiction onto medication almost immediately. It’s seeing early success.
Philadelphia Inquirer | December 1, 2022
CareConnect: Adapting a Virtual Urgent Care Model to Provide Buprenorphine Transitional Care
NEJM Catalyst | November 16, 2022
Redesign of Opioid Use Disorder Screening and Treatment in the ED
NEJM Catalyst | December 15, 2021
High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
JAMA Network Open | July 15, 2021
Methadone and suboxone ® mentions on twitter: thematic and sentiment analysis
Clinical Toxicology | April 6, 2021
Intranasal Naloxone Administration
The New England Journal of Medicine | March 25, 2021
Increasing Short- and Long-Term Buprenorphine Treatment Capacity: Providing Waiver Training for Medical Students
Journal of the Association of American Medical Colleges | February 2, 2021
Utilizing a multi-class classification approach to detect therapeutic and recreational misuse of opioids on Twitter
Computers in Biology and Medicine | February 1, 2021
A theoretical framework and nomenclature to characterize the iatrogenic contribution of therapeutic opioid exposure to opioid induced hyperalgesia, physical dependence, and opioid use disorder
The American Journal of Drug and Alcohol Abuse | September 8, 2020
Is It Time for EDs to Play a Central Role in Opioid Use Disorder Treatment?
ED Management | September 1, 2020
Opioid Overdose Deaths with Buprenorphine Detected in Postmortem Toxicology: a Retrospective Analysis
Journal of Medical Toxicology | July 9, 2020
A Systematic Review of Care Needs for Surgical Patients with Chronic Opioid Use: Rachel French Matthew D. McHugh Eileen Lake J. Margo Brooks Carthon
MEDSURG Nursing | July 1, 2020
Opioid Use Disorder and COVID-19: Crashing of the Crises. Khatri UG, Perrone J.
Journal of Addiction Medicine | June 20, 2020
Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing
Annals of Emergency Medicine | May 3, 2020
Stories to Communicate Individual Risk for Opioid Prescriptions for Back and Kidney Stone Pain: Protocol for the Life STORRIED Multicenter Randomized Clinical Trial
JMIR Research Protocols | April 20, 2020
Participation in a Hospital Incentive Program for Follow-up Treatment for Opioid Use Disorder
JAMA Network Open | January 3, 2020
Clinical
Medications for Opioid Use Disorder (MOUD)
Buprenorphine Low-Dose Induction using a Cross-Tapering Strategy
Methadone Resources for Providers
Pain or Opioid Withdrawal in Hospitalized Patients
Xylazine Withdrawal and Overdose
Xylazine Wounds
Alcohol Use
Substance Use Navigator Team
Success Stories
Education
Students
President’s Engagement Prize
Trainings
Addiction Medicine Fellowship
All About the X Waiver
Working as a Peer in Recovery
Events
Community & Harm Reduction Resources
Community
Community Advisory Board (CAB)
Sustaining Peers in the ED (SPED)
Harm Reduction
All About Fentanyl
All About Xylazine
How to Use Narcan
How to Mitigate Stigma
One-Page Resources
Volunteer & Events Calendar
Join Us at Outreach Events!
Volunteer Harm Reduction Interest Group
Research, Projects & Policy
Our Work
CareConnect Warmline
Addiction Medicine Consult Service
Police-Assisted Diversion (PAD)
Project HOME
PROUD Clinic
NACCHO
Clinical Trials
Research
News
Policy
Publications
About Us
Leadership
Advisory Board
Faculty
CAMP Team
Team Spotlight
Newsletters
Donate
Get Help